Differential effects of indoleamines on auditory choice reaction, selective attention, and pitch discrimination

Neuroscience Letters

Volumn 398, Issue 3, 2006, Pages 310-313

  Schwenzer, Michael ^a,b   Heitkamp, Hans Christian ^b   Mathiak, Klaus ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Auditory perception; Citalopram; Melatonin; Serotonin

Indexed keywords

CITALOPRAM; INDOLEAMINE; MELATONIN; PLACEBO;

ADULT; ARTICLE; AUDITORY RESPONSE; AUDITORY STIMULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DECISION MAKING; DOUBLE BLIND PROCEDURE; HEARING; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELECTIVE ATTENTION; SEROTONINERGIC SYSTEM; TASK PERFORMANCE; VISION;

ADULT; ATTENTION; AUDITORY PERCEPTION; CITALOPRAM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; MALE; MELATONIN; PITCH DISCRIMINATION; REACTION TIME; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 33646359975     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.01.016     Document Type: Article

References (22)

1. Coull J.T. Neural correlates of attention and arousal: insights from electrophysiology, functional neuroimaging and psychopharmacology. Prog. Neurobiol. 55 (1998) 343-361
2. Cransac H., Cottet-Emard J.M., Hellström S., and Peyrin L. Specific sound-induced noradrenergic and serotonergic activation in central auditory structures. Hear. Res. 118 (1998) 151-156
3. Dollins A.B., Lynch H.J., Wurtman R.J., Deng M.H., Kischka K.U., Gleason R.E., and Lieberman H.R. Effect of pharmacological daytime doses of melatonin on human mood and performance. Psychopharmacology 112 (1993) 490-496
4. Dollins A.B., Zhdanova I.V., Wurtman R.J., Lynch H.J., and Deng M.H. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 1824-1828
5. Hasbroucq T., Rihet P., Blin O., and Possamai C.A. Serotonin and human information processing: fluvoxamine can improve reaction time performance. Neurosci. Lett. 229 (1997) 204-208
6. Hautzinger M., Bailer M., Worall H., and Keller F. Beck-Depressions-Inventar BDI, Testhandbuch. second revised ed. (1995), Verlag Hans Huber, Göttingen
7. Hegerl U., and Juckel G. Identifying psychiatric patients with serotonergic dysfunctions by event-related potentials. World J. Biol. Psychiatry 1 (2000) 112-118
8. Hindmarch I. The behavioural toxicity of the selective serotonin reuptake inhibitors. Int. Clin. Psychopharmacol. Suppl. 4 (1995) 13-17
9. Hyttel J., Arnt J., and Sanchez C. The pharmacology of citalopram. Rev. Contemp. Pharmacother. 6 (1995) 271-285
10. Juckel G., Gallinat J., Riedel M., Sokullu S., Schulz C., Moller H.J., Muller N., and Hegerl U. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr. Res. 64 (2003) 115-124
11. van Laar M.W., Volkerts E.R., Verbaten M.N., Trooster S., van Megen H.J., and Kenemans J.L. Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory. Psychopharmacology 162 (2002) 351-363
12. Lader M., Melhuish A., Frcka G., OverØ K.F., and Christensen V. The effects of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy subjects. Eur. J. Clin. Pharmacol. 31 (1986) 183-190
13. Margraf J. Mini-DIPS, Diagnostisches Kurz-Interview bei psychischen Störungen, Handbuch, Interviewleitfaden (1994), Springer-Verlag, Berlin
14. Nathan P.J., Sitaram G., Stough C., Silberstein R.B., and Sali A. Serotonin, noradrenaline and cognitive function: a preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor. Behav. Pharmacol. 11 (2000) 639-642
15. Oke A.F., Carver L.A., Gouvion C.M., and Adams R.N. Three-dimensional mapping of norepiphrenine and serotonin in human thalamus. Brain Res. 763 (1997) 69-78
16. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh Inventory. Neuropsychologia 9 (1971) 97-113
17. Riedel W.J., Eiksman K., Helder A., and Schmitt J.A. Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment. J. Psychopharmacol. 19 (2005) 12-20
18. Rihet P., Hasbroucq T., Blin O., and Possamai C.A. Serotonin and human information processing: an electromyographic study of the effects of fluvoxamine on choice reaction time. Neurosci. Lett. 265 (1999) 143-146
19. Schmitt J.A., Ramaekers J.G., Kruizinga M.J., van Boxtel M.P., Vuurman E.F., and Riedel W.J. Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man. J. Psychopharmacol. 16 (2002) 207-214
20. Sugden D. Melatonin biosynthesis in the mammalian pineal gland. Experientia 45 (1989) 922-932
21. Suhner A., Schlagenhauf P., Tschopp A., Hauri-Bionda R., Friedrich-Koch A., and Stefen R. Impact of melatonin on driving performance. J. Travel. Med. 5 (1998) 7-13
22. Weaver D.R., Stehle J.H., Stopa E.G., and Reppert S.M. Melatonin receptors in human hypothalamus and pituitary: implications for circadian and reproductive responses to melatonin. J. Clin. Endocrinol. Metab. 76 (1993) 295-301